Menu Search
Equities

Hologic Inc

HOLX:NSQ

Hologic Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)82.40
  • Today's Change0.68 / 0.83%
  • Shares traded1.41m
  • 1 Year change+14.41%
  • Beta0.9824
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Hologic Inc's revenues fell -17.12% from 4.86bn to 4.03bn. This along with an increase in the cost of goods sold expense has contributed to a reduction in net income from 1.30bn to 456.00m, a -64.98% decrease.
Gross margin55.41%
Net profit margin17.59%
Operating margin19.69%
Return on assets7.70%
Return on equity13.85%
Return on investment8.64%
More ▼

Cash flow in USDView more

In 2023, Hologic Inc increased its cash reserves by 17.79%, or 416.20m. The company earned 1.05bn from its operations for a Cash Flow Margin of 26.08%. In addition the company used 152.10m on investing activities and also paid 483.20m in financing cash flows.
Cash flow per share4.21
Price/Cash flow per share18.77
Book value per share21.33
Tangible book value per share4.19
More ▼

Balance sheet in USDView more

Hologic Inc has a Debt to Total Capital ratio of 34.08%, a lower figure than the previous year's 54.14%.
Current ratio3.99
Quick ratio3.32
Total debt/total equity0.5169
Total debt/total capital0.3408
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.